SCHEMBL14084028

SCHEMBL14084028

CC(C)Oc1cccc(NC(=O)c2ccc(-c3ncccc3Cl)cn2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 3/20 0.50
▸ SCN2A Q99250 1/20 0.49
▸ SCN10A Q9Y5Y9 1/20 0.49
▸ PLAU P00749 1/20 0.48
▸ TRPV1 Q8NER1 4/20 0.47
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ TSHR P16473 1/20 0.46
▸ CNR1 P21554 1/20 0.46
▸ MAPT P10636 3/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ BRAF P15056 1/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083930 0.90 GRM4 (0.62) GRM4TRPV1MEN1KMT2ATSHR
SCHEMBL14084034 0.88 GRM4 (0.48) GRM4SCN2ASCN10APLAUTRPV1
SCHEMBL14083893 0.88 TRPV1 (0.61) GRM4PLAUTRPV1MEN1KMT2A
SCHEMBL14084016 0.85 P2RX1 (0.51) GRM4SCN2ASCN10ATRPV1TSHR
SCHEMBL14083913 0.84 GRM4 (0.60) GRM4TRPV1MEN1KMT2AMAPT
SCHEMBL14083925 0.82 TRPV1 (0.47) GRM4TRPV1MEN1KMT2AMAPT
SCHEMBL14083947 0.82 CSF1R (0.49) GRM4TRPV1MEN1KMT2AMAPT
SCHEMBL14083912 0.81 TRPV1 (0.56) GRM4TRPV1CNR1KDM4EALDH1A1
SCHEMBL14083054 0.81 P4HTM (0.50) GRM4TRPV1MEN1KMT2AKDM4E
SCHEMBL14083929 0.81 TRPV1 (0.60) GRM4TRPV1MAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 GRM4 362/4885SCN2A 61/4885SCN10A 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback